Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects (scientific article published on 22 July 2014)

Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.

Q54334733

Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections.

Q54343999

Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.

Q54349458

Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.

Q54435607

Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.

Q54590227

Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli

Q56944671

Fluoroquinolone Resistance Mechanisms in Urinary Tract Pathogenic Escherichia coli Isolated During Rapidly Increasing Fluoroquinolone Consumption in a Low-Use Country

Q63761921

Origins and evolution of antibiotic resistance

Q29617791

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

Q30396308

Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.

Q33464072

Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes

Q33962732

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

Q34096605

Inhibitors of bacterial topoisomerases: mechanisms of action and resistance and clinical aspects

Q34196521

Clinical practice. Uncomplicated urinary tract infection

Q34261256

Resistance to trimethoprim and sulfonamides

Q34296633

Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009).

Q34552718

Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment.

Q34567950

Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection

Q35806315

Antibiotic resistance in bacteria and its future for novel antibiotic development

Q36485560

European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis

Q36845365

Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.

Q37263346

Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection

Q37392904

Type II topoisomerases--inhibitors, repair mechanisms and mutations

Q37599175

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.

Q37671098

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.

Q37899179

Mycobacterium tuberculosis: immune evasion, latency and reactivation.

Q37911031

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

Q37957839

Metallo-β-lactamase structure and function

Q38060809

Commonality among fluoroquinolone-resistant sequence type ST131 extraintestinal Escherichia coli isolates from humans and companion animals in Australia

Q41878231

Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo

Q42063682

Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance

Q42861089

A module located at a chromosomal integration hot spot is responsible for the multidrug resistance of a reference strain from Escherichia coli clonal group A.

Q43121845

Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli

Q43195414

Sulfonamides and trimethoprim

Q43218783

Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections

Q44454310

Nitrofurantoin-induced lung- and hepatotoxicity.

Q44700271

French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy

Q45269705

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

Q45977952

First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan

Q46161139

Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes

Q46714399

Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli

Q46877795

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

main subject

urinary tract infection

Q221668

antibiotic resistance

Q380775

P304

page(s)

341-352

P577

publication date

2014-07-22

P1433

published in

Antibiotics (Basel, Switzerland)

Q27725829

P1476

title

Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects

P478

volume

Reverse relations

cites work (P2860)

Q89697699	Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis
Q92028518	Comparative Epidemiology and Resistance Trends of Common Urinary Pathogens in a Tertiary-Care Hospital: A 10-Year Surveillance Study
Q92362913	Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study
Q100737178	Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends
Q90040795	Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot
Q92879658	Resistance Trends and Epidemiology of Citrobacter-Enterobacter-Serratia in Urinary Tract Infections of Inpatients and Outpatients (RECESUTI): A 10-Year Survey

P356	DOI	10.3390/ANTIBIOTICS3030341
P932	PMC publication ID	4790371
P698	PubMed publication ID	27025749